GeneDx outlines $540M-$555M 2026 revenue target as company accelerates market expansion with new sales force
Source: SeekingAlpha
2026-02-23 12:36:45 ET
More on GeneDx Holdings
- GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
- GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- GeneDx Holdings Non-GAAP EPS of $0.18 beats by $0.06, revenue of $121M beats by $0.56M
- GeneDx Holdings Corp. Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
GeneDx outlines $540M–$555M 2026 revenue target as company accelerates market expansion with new sales force
GeneDx Holdings Corp. Warrant
NASDAQ: WGSWW
WGSWW Trading
71.11% G/L:
$0.0154 Last:
88,095 Volume:
$0.0143 Open:
WGSWW Latest News
WGSWW Stock Data
$2,637,254,684
20,348,831
N/A
111
N/A
Medical Diagnostics & Screening
Healthcare
US
Stamford
